PAPER Ge R, Sun X
SEARCH RESULTS
330986 RESULTS
PAPER Karran E, Mercken M, De Strooper B
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
Nat Rev Drug Discov. 2011 Sep;10(9):698-712. PubMed: 21852788PAPER Marin R
Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.
Front Physiol. 2011;2:23. PubMed: 21852974PAPER Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, Engler H
In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2202-8. PubMed: 21853308PAPER Mendelsohn AR, Larrick JW
Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.
Rejuvenation Res. 2011 Aug;14(4):437-41. PubMed: 21851176PAPER Stieren ES, El Ayadi A, Xiao Y, Siller E, Landsverk ML, Oberhauser AF, Barral JM, Boehning D
Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein.
J Biol Chem. 2011 Oct 14;286(41):35689-98. PubMed: 21852239PAPER Venturelli M, Scarsini R, Schena F
Six-month walking program changes cognitive and ADL performance in patients with Alzheimer.
Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. PubMed: 21852281Qiliu Peng
Guangxi Medical UniversityChina
PAPER Tu T, Tu AT, Lin TS